These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 33055159)

  • 21. Cardiovascular side-effects of modern cancer therapy.
    Minami M; Matsumoto S; Horiuchi H
    Circ J; 2010 Sep; 74(9):1779-86. PubMed ID: 20716834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological foundations of cardio-oncology.
    Minotti G; Salvatorelli E; Menna P
    J Pharmacol Exp Ther; 2010 Jul; 334(1):2-8. PubMed ID: 20335321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular Toxicities in Pediatric Cancer Survivors.
    Ryan TD; Nagarajan R; Godown J
    Cardiol Clin; 2019 Nov; 37(4):533-544. PubMed ID: 31587793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Vascular Complications Of Cancer Chemotherapy].
    Belenkov YN; Privalova EV; Kozhevnikova MV; Kirichenko YY
    Kardiologiia; 2018 Sep; 58(Suppl 9):4-9. PubMed ID: 30312566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors.
    Steingart RM; Bakris GL; Chen HX; Chen MH; Force T; Ivy SP; Leier CV; Liu G; Lenihan D; Lindenfeld J; Maitland ML; Remick SC; Tang WH
    Am Heart J; 2012 Feb; 163(2):156-63. PubMed ID: 22305831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular toxicity caused by cancer treatment: strategies for early detection.
    Altena R; Perik PJ; van Veldhuisen DJ; de Vries EG; Gietema JA
    Lancet Oncol; 2009 Apr; 10(4):391-9. PubMed ID: 19341970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy-induced cardiotoxicity: detection, prevention, and management.
    Truong J; Yan AT; Cramarossa G; Chan KK
    Can J Cardiol; 2014 Aug; 30(8):869-78. PubMed ID: 25064580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antineoplastic drugs inducing cardiac and vascular toxicity - An update.
    Barachini S; Ghelardoni S; Varga ZV; Mehanna RA; Montt-Guevara MM; Ferdinandy P; Madonna R
    Vascul Pharmacol; 2023 Dec; 153():107223. PubMed ID: 37678516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanisms for vascular complications of targeted cancer therapies.
    Gopal S; Miller KB; Jaffe IZ
    Clin Sci (Lond); 2016 Oct; 130(20):1763-79. PubMed ID: 27612952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cancer and cardiovascular risk].
    Blanch Gracia P; Mena Sebastià E; Villanueva Vázquez R; Tirapu Sola L; Losa Gaspà F; Freixa-Pamias R; Armario P
    Hipertens Riesgo Vasc; 2021; 38(3):e1-e9. PubMed ID: 33706995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heart matters: cardiovascular complications related to cancer treatment.
    Altena R; van Veldhuisen DJ
    Future Oncol; 2013 Feb; 9(2):137-40. PubMed ID: 23414462
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardioncology: state of the heart.
    Todaro MC; Oreto L; Qamar R; Paterick TE; Carerj S; Khandheria BK
    Int J Cardiol; 2013 Sep; 168(2):680-7. PubMed ID: 23639459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Educational paper: decreasing the burden of cardiovascular disease in childhood cancer survivors: an update for the pediatrician.
    Dillenburg RF; Nathan P; Mertens L
    Eur J Pediatr; 2013 Sep; 172(9):1149-60. PubMed ID: 23361962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular safety of oncologic agents: a double-edged sword even in the era of targeted therapies - Part 2.
    Manolis AA; Manolis TA; Mikhailidis DP; Manolis AS
    Expert Opin Drug Saf; 2018 Sep; 17(9):893-915. PubMed ID: 30126303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein Quality Control Dysfunction in Cardiovascular Complications Induced by Anti-Cancer Drugs.
    Fu HY; Mukai M; Awata N; Sakata Y; Hori M; Minamino T
    Cardiovasc Drugs Ther; 2017 Feb; 31(1):109-117. PubMed ID: 28120277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Onco-Cardiology - From the Standpoint of Cardiology].
    Shioyama W
    Gan To Kagaku Ryoho; 2017 Dec; 44(13):2052-2057. PubMed ID: 29361616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical roles of vascular function assessment in cancer care.
    Sawami K; Tanaka A; Node K
    Support Care Cancer; 2022 Feb; 30(2):985-987. PubMed ID: 34378082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging cancer therapies and cardiovascular risk.
    Bottinor W; Parikh A; Jahangir E
    J Thromb Thrombolysis; 2021 May; 51(4):837-845. PubMed ID: 32886244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insights into cardiovascular side-effects of modern anticancer therapeutics.
    Stortecky S; Suter TM
    Curr Opin Oncol; 2010 Jul; 22(4):312-7. PubMed ID: 20535072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term arterial complications of chemotherapy in patients with cancer.
    Svilaas T; Lefrandt JD; Gietema JA; Kamphuisen PW
    Thromb Res; 2016 Apr; 140 Suppl 1():S109-18. PubMed ID: 27067963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.